Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kaplan Myron, holds the title of Director at CorMedix Inc..
On 2026-11-16, the insider transacted 25,000 shares.The shares were transacted at a weighted average price of $4.88 per share, resulting in a total market-relevant value of $122K.
Kaplan Myron (Director) bought $122K of $CRMD
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.